Cart summary

You have no items in your shopping cart.

RRX-001

SKU: orb1223635

Description

RRX-001 (RRX001) is a novel NO and hypoxia mediated anticancer agent with with epigenetic and immunologic activity; targets CD133 + /CD44 + cancer stem cells from colon cancer cell-lines, HT-29, Caco-2, and HCT116, and inhibits Wnt pathway signalling with downregulation of c-Myc; inhibits HCT 116 and decreases levels of the DNA methyltransferases DNMT1 and DNMT3a in a time and dose-dependent manner; RRX-001 (RRX001) is a chemosensitizer in multiple tumor types and disease states including malaria, hemorrhagic shock and sickle cell anemia.Lung Cancer Phase 2 Clinical.

Images & Validation

Key Properties

CAS Number925206-65-1
MW268.023
Purity>98% (HPLC)
FormulaC5H6BrN3O5
SMILESO=[N+](C1([N+]([O-])=O)CN(C(CBr)=O)C1)[O-]
TargetOther Targets
SolubilityDMSO : ≥ 100 mg/mL 373.11 mM

Bioactivity

In Vivo
Animal model: CB-17 SCID-mice were subcutaneously inoculated with 5.0 × 106 MM. 1S cells in 100 μL of serum-free RPMI 1640 medium. Dosage: 5 mg/kg or 10 mg/kg. Administration: I. V. , thrice-weekly for 24 days. Result: Blocked MM tumor growth and enhances survival. Treatment was well tolerated, suggested by no apparent weight loss. Animal model: Female BALB/c nude mice (19.2 ± 1.7 g) based on A549 lung cancer model. Dosage: 10 mg/kg. Administration: IP, twice a week and once a day. Result: Resulted in the most significant tumor growth retardation. Reduction of resident macrophages in tumor-bearing mice attenuates the antitumor activity of RRx-001.
In Vitro
Cell Viability Assay Cell line: Human MM-cell lines (MM.1S, RPMI-8226, H929, ARP1, KMS-11, OPM2, LR5, ANBL6.WT), along with drug resistant cell lines such as (MM.1R, Dox40, LR5, ANBL6.BR, RPMI-8226). Concentration: 0-5 μM. Incubation time: 24 hours. Result: Induced a dose-dependent significant (p < 0.05) decrease in viability of all cell lines.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

RRX001 | RRX 001

Similar Products

  • RRX-001 [orb1299853]

    99.91%

    925206-65-1

    268.02

    C5H6BrN3O5

    2 mg, 5 mg, 10 mg, 50 mg, 100 mg, 1 mg, 500 mg, 1 ml x 10 mM (in DMSO), 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

RRX-001 (orb1223635)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

2 mg
$ 120.00
5 mg
$ 180.00
10 mg
$ 230.00
25 mg
$ 410.00
50 mg
$ 690.00
100 mg
$ 990.00
500 mg
$ 2,020.00